Feasibility and safety of laparoscopic lateral pelvic lymph node dissection for locally recurrent rectal cancer and risk factors for re‐recurrence
- 18 December 2019
- journal article
- research article
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 13 (4) , 489-497
Abstract
Introduction Lateral pelvic lymph node (LPLN) metastasis is considered a distant metastasis. It is often treated by systemic chemotherapy and/or radiation therapy, but complete radical resection of LPLN metastasis can sometimes achieve cure. However, the safety and efficacy of radical resection for recurrent LPLN after curative rectal surgery have not been well elucidated. Therefore, we evaluated the feasibility of laparoscopic radical surgery for recurrent LPLN compared with the conventional open approach and assessed oncological outcomes between patients with and without re‐recurrence. Methods We retrospectively reviewed 17 cases (4 open, 13 laparoscopic) who underwent radical resection for LPLN metastasis after curative rectal surgery between July 2012 and August 2016 at the National Hospital Organization Osaka National Hospital. Operative factors and short‐term outcomes were compared. Oncological outcome was evaluated based on the pathologic response to preoperative adjuvant therapy. Results The laparoscopic group's median blood loss and C‐reactive protein elevation were lower than that of the open group on postoperative day 3. The laparoscopic group also had a shorter postoperative hospital stay. The median operative time, R0 resection rate, and morbidity rate were similar between the two groups. Local re‐recurrence after LPLN resection occurred more frequently in pathologic non‐responders than responders. Conclusion Laparoscopic surgery for LPLN metastasis is feasible and less invasive than open surgery. Laparoscopic radical resection of LPLN may be justified for curative intent. Patients with incomplete pathologic response to neoadjuvant therapy have a greater risk of re‐recurrence.Keywords
This publication has 27 references indexed in Scilit:
- Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approachSurgical Endoscopy, 2015
- Selective Lateral Pelvic Lymph Node Dissection in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy Based on Pretreatment ImagingAnnals of Surgical Oncology, 2013
- Results of a Japanese Nationwide Multi-Institutional Study on Lateral Pelvic Lymph Node Metastasis in Low Rectal CancerAnnals of Surgery, 2012
- Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trialThe Lancet Oncology, 2012
- Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal CancerAnnals of Surgical Oncology, 2010
- Current management of locally recurrent rectal cancerColorectal Disease, 2009
- Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancerInternational Journal of Colorectal Disease, 2009
- A Population-Based Study on the Management and Outcome in Patients with Locally Recurrent Rectal CancerAnnals of Surgical Oncology, 2006
- Indication and Benefit of Pelvic Sidewall Dissection for Rectal CancerDiseases of the Colon & Rectum, 2006
- Developments and quality assurance in rectal cancer surgeryEuropean Journal of Cancer, 2002